who should not take glp-1 drugs Medications for Weight Loss: Semaglutide vs Tirzepatide vs Retat – Revolution Health & Wellness Use of GLP-1 drugs early

However, because even in this pooled analyses the number of events of pancreatitis was still relatively small, we believe that these numbers alone neither prove nor disprove an association between incretin-based therapies and pancreatitis

Clinical Effectiveness and Safety of Once-Weekly GLP-1 Receptor Agonist Dulaglutide as Add-On to Metformin or Metformin Plus Insulin Secretagogues in Obesity and Type 2 Diabetes

Read our full review here: Shed GLP-1 Clinic Review 3

10.1186/s12967-016-0985-7

The key indicator is whether you are experiencing meaningful appetite reduction

Non-peptidic oral GLP-1RAs may eventually reduce supply pressures because they do not require peptide synthesis or cold-chain storage, but this will depend on scalable, cost-efficient manufacturing pathways